FOXM1 Apt was confirmed to prevent the binding of FOXM1 to its consensus binding sites in promoters and consequently suppress FOXM1 transcriptional activities, resulting in the downregulation of the expression of FOXM1 target genes and the inhibition of cancer cell proliferation. The gene discussed is FOXM1; the disease is cancer.